Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - BioXcel Therapeutics, Inc. | StockGist | StockGist

Companies
BTAI
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings BTAISCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

BioXcel Therapeutics, Inc.

Filed Oct 1, 2025

Accepted Sep 30, 2025, 8:00 PM ET

CIK 0001720893

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

BioXcel Therapeutics, Inc.

Person Type

OO

CUSIP: 09075P204

Amendment History

4 filings

SCHEDULE 13G
Original
Viewing
Oct 1, 20250001104659-25-095634
SCHEDULE 13G/A
Amendment 1
May 15, 20250001172661-25-002273
SCHEDULE 13G/A
Amendment 2
May 15, 20250001140361-25-019286
SCHEDULE 13G/A
Amendment 3
Latest
Mar 30, 20260001441449-26-000004

Recent Filings

BioXcel Therapeutics, Inc.3 days ago

BioXcel Therapeutics, Inc.5 days ago

BioXcel Therapeutics, Inc.1 weeks ago

BioXcel Therapeutics, Inc.3 weeks ago

BioXcel Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice